Home LiteratureArticle Details
PMID: 18558024 Published · ppublish English Journal Article

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Preventing chronic disease ·Vol. 5 ·No. 3 ·2008-07-00 ·Pages A74

Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP

Abstract

Previous studies indicate that the incidence of hepatocellular carcinoma in the United States is increasing. These reports, however, have contained limited information on population groups other than whites and blacks. We assessed recent incidence rates and trends for hepatocellular carcinoma by using newly available national data from cancer registries participating in the Centers for Disease Control and Prevention's National Program of Cancer Registries and the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. Data from registries in 38 states and the District of Columbia met our criteria; these data covered 83% of the U.S. population. We computed age-adjusted incidence rates and annual percentages of change from 1998 through 2003. The registries that we used reported 48,048 cases of hepatocellular carcinoma (3.4 cases per 100,000 population per year) for the study period. Whites accounted for three-fourths of cases. The incidence rate for blacks was 1.7 times higher than that for whites, and the rate for Asians/Pacific Islanders was 4 times higher than that for whites. Hispanics had 2.5 times the risk of non-Hispanics. Among Asian/Pacific Islander subgroups, rates were highest for people of Vietnamese and Korean origin. For all races/ethnicities combined, the annual percentages of change were 4.8% for males and 4.3% for females (P < .05). The annual percentage of change was highest for people aged 45-59 years (9.0%, P < .05). The annual percentage of change for Asians/Pacific Islanders was statistically unchanged. We document rising incidence rates of hepatocellular carcinoma in the United States during a time when the overall incidence of cancer has stabilized. Efforts to collect representative etiologic data on new hepatocellular carcinoma cases are needed to enable better characterization of trends and to guide the planning and evaluation of prevention programs.

MeSH Terms
Adult Aged Aged, 80 and over Carcinoma, Hepatocellular/ethnology Female Humans Incidence Liver Neoplasms/ethnology Male Middle Aged Racial Groups/statistics & numerical data SEER Program Time Factors United States/epidemiology
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ahmed Faruque
Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-52, Atlanta, GA 30333, USA. [email protected]
Perz Joseph F
Kwong Sandy
Jamison Patricia M
Friedman Carol
Bell Beth P
References (33)
33 references, click to expand
  1. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
    Am J Gastroenterol. 2003 Sep;98(9):2060-3 PMID: 14499788
  2. Diagnosis, management, and treatment of hepatitis C.
    Hepatology. 2004 Apr;39(4):1147-71 PMID: 15057920
  3. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    Hepatology. 2004 Mar;39(3):798-803 PMID: 14999699
  4. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
    MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31 PMID: 16371945
  5. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50 PMID: 15508101
  6. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations.
    Cancer. 2006 Oct 15;107(8):1711-42 PMID: 16958083
  7. Liver cancer in Asian migrants to the United States and their descendants.
    Cancer Causes Control. 1996 May;7(3):345-50 PMID: 8734828
  8. What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
    J Fam Pract. 2006 Feb;55(2):155-6; discussion 155 PMID: 16451784
  9. The global health burden of infection-associated cancers in the year 2002.
    Int J Cancer. 2006 Jun 15;118(12):3030-44 PMID: 16404738
  10. Asian subgroups and cancer incidence and mortality rates in California.
    Cancer. 2005 Dec 15;104(12 Suppl):2975-81 PMID: 16247792
  11. Hepatocellular carcinoma: recent trends in the United States.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34 PMID: 15508094
  12. Liver, gallbladder, extrahepatic bile ducts, and pancreas.
    Cancer. 1995 Jan 1;75(1 Suppl):171-90 PMID: 8000995
  13. Pathogenesis of hepatitis C-associated hepatocellular carcinoma.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S62-71 PMID: 15508105
  14. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
    Cancer. 2001 Mar 1;91(5):1046-51 PMID: 11251958
  15. Hepatocellular carcinoma: summary and recommendations.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S319-23 PMID: 15508100
  16. Cancer statistics by race and ethnicity.
    CA Cancer J Clin. 1998 Jan-Feb;48(1):31-48 PMID: 9449932
  17. Hepatitis C: a bitter harvest.
    Ann Intern Med. 2006 May 16;144(10):770-1 PMID: 16702593
  18. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.
    Am J Public Health. 1999 Jan;89(1):14-8 PMID: 9987458
  19. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.
    Pediatrics. 2006 Oct;118(4):1403-8 PMID: 17015529
  20. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
    Cancer. 2004 Jul 1;101(1):3-27 PMID: 15221985
  21. Hepatocellular carcinoma: an epidemiologic view.
    J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8 PMID: 12394209
  22. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
    Hepatology. 2000 Mar;31(3):777-82 PMID: 10706572
  23. Confidence intervals for directly standardized rates: a method based on the gamma distribution.
    Stat Med. 1997 Apr 15;16(7):791-801 PMID: 9131766
  24. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies.
    Cancer Causes Control. 2007 Mar;18(2):177-87 PMID: 17219013
  25. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
    Ann Intern Med. 2006 May 16;144(10):705-14 PMID: 16702586
  26. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities.
    CA Cancer J Clin. 2007 Jul-Aug;57(4):190-205 PMID: 17626117
  27. Hepatitis B virus infection: epidemiology and vaccination.
    Epidemiol Rev. 2006;28:112-25 PMID: 16754644
  28. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
    J Gastroenterol Hepatol. 1996 Oct;11(10):949-54 PMID: 8912133
  29. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
    Am J Gastroenterol. 1999 Oct;94(10):2988-93 PMID: 10520857
  30. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
    N Engl J Med. 1997 Jun 26;336(26):1855-9 PMID: 9197213
  31. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.
    Ann Intern Med. 2003 Nov 18;139(10):817-23 PMID: 14623619
  32. Primary liver cancer: worldwide incidence and trends.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16 PMID: 15508102
  33. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.
    Cancer. 2007 May 15;109(10):2100-8 PMID: 17385214
Article Info
Journal
Preventing chronic disease
Abbr.
Prev Chronic Dis
ISSN
1545-1151
Published
2008-07-00
Epub
2008-00-15
Pages
A74
Language
English
Region
United States
NLM ID
101205018
PMCID
PMC2483571
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]